raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:95713

Athyreosis

Type
Morphological anomaly
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Infancy, Neonatal
Status
active

A rare form of thyroid dysgenesis characterized by complete absence of thyroid tissue that results in primary congenital hypothyroidism, a permanent thyroid deficiency that is present from birth.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAthyreosis
frAthyréose
deAthyreose
esAtireosis
itAtireosi
nlAthyreose
ptAtireose
plAtyreoza
csAtyreóza
ukАтиреоз
zh无甲状腺症
trAtireozis

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM218700NTBTvalidated
OMIM225250BTNTvalidated
ICD-10E03.1NTBTattributedvalidated
ICD-115A00.01NTBTindexvalidated
MONDO0019855Evalidated
UMLSC4305275Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

6 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
FOXE1Candidate gene tested inNot yet assessedHGNC:3806ENSG000001789196026179q22.33forkhead box E128455095[PMID]
NKX2-1Candidate gene tested inNot yet assessedHGNC:11825ENSG0000013635260063514q13.3NK2 homeobox 128455095[PMID]
PAX8Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:8622ENSG000001256181674152q14.1paired box 825905381[PMID]
SLC26A4Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:8818ENSG000000911376056467q22.3solute carrier family 26 member 424248179[PMID]
TSHRDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:12373ENSG0000016540960337214q24-q31thyroid stimulating hormone receptor14725684[PMID]
NKX2-5Disease-causing germline mutation(s) inAssessedHGNC:2488ENSG000001830726005845q35.1NK2 homeobox 516418214[PMID]_25905381[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0003.5 / 100 000EuropeValue and classValidated[EXPERT]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

25 annotations · validated 2024-10-09
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003270Abdominal distention
HP:0025483Abnormal circulating thyroglobulin concentration
HP:0000271Abnormality of the face
HP:0000280Coarse facial features
HP:0002019Constipation
HP:0012378Fatigue
HP:0011968Feeding difficulties
HP:0100786Hypersomnia
HP:0000821Hypothyroidism
HP:0001252Hypotonia
HP:0000239Large fontanelles
HP:0000158Macroglossia
HP:0001324Muscle weakness
HP:0008191Thyroid agenesis
Frequent (79-30%)
HP:0033850Coldness
HP:0000282Facial edema
HP:0001263Global developmental delay
HP:0001510Growth delay
HP:0001615Hoarse cry
HP:0010864Intellectual disability, severe
HP:0001254Lethargy
HP:0006579Prolonged neonatal jaundice
HP:0004322Short stature
HP:0001537Umbilical hernia
HP:0008282Unconjugated hyperbilirubinemia

Run the differential on the 12 obligate / very frequent terms

Annotation source: 25905261[PMID]

7

Sources for this card